Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1130279.RAdTrx3hBcvx0pJu_SNH-Sl9PT13CM_zTtDFgBrukI5r0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1130279.RAdTrx3hBcvx0pJu_SNH-Sl9PT13CM_zTtDFgBrukI5r0130_assertion type Assertion NP1130279.RAdTrx3hBcvx0pJu_SNH-Sl9PT13CM_zTtDFgBrukI5r0130_head.
- NP1130279.RAdTrx3hBcvx0pJu_SNH-Sl9PT13CM_zTtDFgBrukI5r0130_assertion description "[In this study, disabling the eIF4F complex by targeting eIF4E with eIF4E-specific antisense oligonucleotide (4EASO) is assessed as a therapy for mesothelioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1130279.RAdTrx3hBcvx0pJu_SNH-Sl9PT13CM_zTtDFgBrukI5r0130_provenance.
- NP1130279.RAdTrx3hBcvx0pJu_SNH-Sl9PT13CM_zTtDFgBrukI5r0130_assertion evidence source_evidence_literature NP1130279.RAdTrx3hBcvx0pJu_SNH-Sl9PT13CM_zTtDFgBrukI5r0130_provenance.
- NP1130279.RAdTrx3hBcvx0pJu_SNH-Sl9PT13CM_zTtDFgBrukI5r0130_assertion SIO_000772 24260583 NP1130279.RAdTrx3hBcvx0pJu_SNH-Sl9PT13CM_zTtDFgBrukI5r0130_provenance.
- NP1130279.RAdTrx3hBcvx0pJu_SNH-Sl9PT13CM_zTtDFgBrukI5r0130_assertion wasDerivedFrom befree-2016 NP1130279.RAdTrx3hBcvx0pJu_SNH-Sl9PT13CM_zTtDFgBrukI5r0130_provenance.
- NP1130279.RAdTrx3hBcvx0pJu_SNH-Sl9PT13CM_zTtDFgBrukI5r0130_assertion wasGeneratedBy ECO_0000203 NP1130279.RAdTrx3hBcvx0pJu_SNH-Sl9PT13CM_zTtDFgBrukI5r0130_provenance.